Robert E. Mosser

Array ( [id] => 6378589 [patent_doc_number] => 20100081702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF HEPATITIS' [patent_app_type] => utility [patent_app_number] => 12/624214 [patent_app_country] => US [patent_app_date] => 2009-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2831 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081702.pdf [firstpage_image] =>[orig_patent_app_number] => 12624214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432319 [patent_doc_number] => 20100152200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'ALPHAVIRUS INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/619117 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10497 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152200.pdf [firstpage_image] =>[orig_patent_app_number] => 12619117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6543855 [patent_doc_number] => 20100125081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => 'NEW COMPOUNDS 574' [patent_app_type] => utility [patent_app_number] => 12/618088 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33793 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20100125081.pdf [firstpage_image] =>[orig_patent_app_number] => 12618088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257270 [patent_doc_number] => 08206748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Powdery composition for nasal administration' [patent_app_type] => utility [patent_app_number] => 12/610901 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14978 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 300 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12610901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6594740 [patent_doc_number] => 20100048528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'HETEROCYCLIC COMPOUNDS AS INHIBITORS OF BETA-LACTAMASES' [patent_app_type] => utility [patent_app_number] => 12/610562 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38403 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048528.pdf [firstpage_image] =>[orig_patent_app_number] => 12610562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937412 [patent_doc_number] => 20110212913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'THERAPEUTIC COMPOSITIONS COMPRISING PHENOLIC ACIDS FOR TREATING CONDITIONS RELATED TO INAPPROPRIATE PLATELET AGGREGATION' [patent_app_type] => utility [patent_app_number] => 13/126137 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17513 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212913.pdf [firstpage_image] =>[orig_patent_app_number] => 13126137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321564 [patent_doc_number] => 20100113530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'S1P LYASE INHIBITORS FOR THE TREATMENT OF CEREBRAL MALARIA' [patent_app_type] => utility [patent_app_number] => 12/608426 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15047 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113530.pdf [firstpage_image] =>[orig_patent_app_number] => 12608426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662367 [patent_doc_number] => 08809344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Compounds, compositions, and methods for control of hepatitis C viral infections' [patent_app_type] => utility [patent_app_number] => 13/126619 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21808 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321004 [patent_doc_number] => 20100113461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'SUBSTITUTED HETEROCYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/606956 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23211 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113461.pdf [firstpage_image] =>[orig_patent_app_number] => 12606956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555284 [patent_doc_number] => 08329755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Methods for treating retroviral infections' [patent_app_type] => utility [patent_app_number] => 12/606320 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48161 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12606320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454646 [patent_doc_number] => 20100105662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Besifloxacin Ophthalmic Composition for the Treatment or Control of Infection' [patent_app_type] => utility [patent_app_number] => 12/604422 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22556 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105662.pdf [firstpage_image] =>[orig_patent_app_number] => 12604422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064439 [patent_doc_number] => 20110201659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'AGENT FOR PREVENTING OR TREATING ZOSTER-ASSOCIATED PAIN' [patent_app_type] => utility [patent_app_number] => 13/125100 [patent_app_country] => US [patent_app_date] => 2009-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6107 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201659.pdf [firstpage_image] =>[orig_patent_app_number] => 13125100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062040 [patent_doc_number] => 20110200554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'THERAPEUTIC AGENT FOR HEPATITIS C' [patent_app_type] => utility [patent_app_number] => 13/124584 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2913 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200554.pdf [firstpage_image] =>[orig_patent_app_number] => 13124584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328757 [patent_doc_number] => 08236849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Model for glutamate racemase inhibitors and glutamate racemase antibacterial agents' [patent_app_type] => utility [patent_app_number] => 12/580238 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 4843 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12580238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276303 [patent_doc_number] => 20100256209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'COMPOSITIONS COMPRISING ETHER COMPOUNDS AND PHARMACEUTICAL USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/579752 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 42866 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256209.pdf [firstpage_image] =>[orig_patent_app_number] => 12579752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388156 [patent_doc_number] => 20100317637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'ANTI-HEPATITIS C COMPOSITION AND METHOD FOR PREPARING DRUG FOR INHIBITING HEPATITIS C VIRUSES OR TREATING HEPATITIS C' [patent_app_type] => utility [patent_app_number] => 12/573116 [patent_app_country] => US [patent_app_date] => 2009-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3528 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317637.pdf [firstpage_image] =>[orig_patent_app_number] => 12573116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6249153 [patent_doc_number] => 20100137313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/572436 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 298951 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137313.pdf [firstpage_image] =>[orig_patent_app_number] => 12572436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959677 [patent_doc_number] => 20110184064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'THERAPEUTIC AGENT FOR HEPATITIS C' [patent_app_type] => utility [patent_app_number] => 13/121645 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9018 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20110184064.pdf [firstpage_image] =>[orig_patent_app_number] => 13121645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527873 [patent_doc_number] => 08304443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Indazole derivatives' [patent_app_type] => utility [patent_app_number] => 12/569324 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57446 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12569324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791657 [patent_doc_number] => 20120053213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => '2-(4-SUBSTITUTED PHENYLAMINO) POLYSUBSTITUTED PYRIDINE COMPOUNDS AS INHIBITORS OF NON-NUCLEOSIDE HIV REVERSE TRANSCRIPTASE, PREPARATION METHODS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/123494 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16404 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053213.pdf [firstpage_image] =>[orig_patent_app_number] => 13123494 [rel_patent_id] =>[rel_patent_doc_number] =>)